How long before a colonoscopy should non-colonoscopy related suppositories be stopped?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discontinuation of Non-Colonoscopy Related Suppositories Before Colonoscopy

Non-colonoscopy related suppositories should be discontinued at least 2 hours before a colonoscopy procedure, following the same guidelines as other clear liquids and bowel preparation agents. 1

Rationale for the 2-Hour Rule

The timing recommendation is based on several key factors:

  1. American Society of Anesthesiologists (ASA) Guidelines: The 2023 ASA updated practice guidelines state that patients may consume clear liquids up to 2 hours before anesthesia or procedural sedation 1. This applies to suppositories as well, which are considered similar to clear liquids in terms of gastric emptying.

  2. Gastric Emptying Considerations: Studies have shown that the rate of gastric emptying of bowel preparations and other clear liquids is similar, with no excess gastric volumes when following the 2-hour cutoff rule 1.

  3. Optimal Bowel Preparation Timing: The US Multi-Society Task Force on Colorectal Cancer strongly recommends that all bowel preparation agents be completed at least 2 hours before the procedure start time 1.

Special Considerations

Types of Suppositories

Different types of suppositories may have different considerations:

  • Bisacodyl suppositories: Often used as part of bowel preparation regimens 2, 3. When used for this purpose, they should be administered according to the bowel preparation protocol.

  • Medication-containing suppositories: For non-colonoscopy related suppositories (such as those containing medications for pain, hemorrhoids, or other conditions), the same 2-hour rule applies.

Patient-Specific Factors

Certain patient conditions may require additional precautions:

  • Patients with GI disorders: Those with significant uncontrolled reflux disease, hiatal hernia, Zenker diverticulum, achalasia, stricture, previous gastric surgery, gastroparesis, or diabetes mellitus may require individualized timing considerations 1.

  • Patients on GLP-1 receptor agonists: These medications delay gastric emptying and may affect the timing. The ASA advises stopping these agents 1-7 days before an elective procedure 1.

Practical Implementation

  1. Instruct patients clearly: Provide both verbal and written instructions about stopping suppositories at least 2 hours before the procedure 1.

  2. Coordinate with medication schedules: If the suppository is medically necessary, work with the patient to adjust the timing of administration to maintain therapeutic effect while adhering to the 2-hour cutoff.

  3. Document compliance: Ask patients about suppository use during the pre-procedure assessment.

Potential Complications of Non-Compliance

Failure to follow the 2-hour rule could potentially lead to:

  • Aspiration risk: Though studies show minimal risk when following the 2-hour guideline 1.

  • Procedure delays: If there are concerns about recent suppository use, the procedure might be delayed.

  • Interference with bowel preparation quality: Some suppositories might affect the quality of bowel preparation if used too close to the procedure time.

Common Pitfalls to Avoid

  • Assuming all suppositories are part of bowel preparation: Clearly distinguish between suppositories used for bowel preparation and those used for other medical purposes.

  • Overly restrictive timing: Requiring discontinuation more than 2 hours before the procedure is not evidence-based and may unnecessarily interfere with patient comfort or medical treatment.

  • Failing to communicate clearly: Ensure patients understand that the 2-hour rule applies to all rectal medications, not just oral intake.

By following these evidence-based guidelines, healthcare providers can ensure patient safety while maintaining optimal conditions for colonoscopy procedures.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.